1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Toreador Therapeutics Inc. currently manages 1 pending office action. This action is assigned to examiner MARCSISIN, ELLEN JEAN, who is the busiest examiner for the portfolio with 1 pending matter. The data shows 1 distinct examiner and 0 distinct art units are involved in the prosecution. For a practitioner, this means the entirety of the company's active patent work is being reviewed by a single individual. There are no other pending cases to provide a comparative view of examiner behavior for this company. With 1 distinct examiner and 0 distinct art units, the prosecution profile is extremely focused on this single pending office action.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MARCSISIN, ELLEN JEAN | 1 | 34.6% | +49.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18706534 | METHODS AND SYSTEMS FOR SUPER-RESOLUTION STUDY OF THERAPIES | MARCSISIN, ELLEN JEAN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18706534 | METHODS AND SYSTEMS FOR SUPER-RESOLUTION STUDY OF THERAPIES | MARCSISIN, ELLEN JEAN | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18706534 | METHODS AND SYSTEMS FOR SUPER-RESOLUTION STUDY OF THERAPIES | MARCSISIN, ELLEN JEAN | — | §103§112 | Non-Final OA | — | Pending | May 01, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialToreador Therapeutics Inc. has 1 pending office actions as of October 2026, spread across 0 art units and 1 examiners.
Ellen Jean Marcsisin has the most, with 1 of Toreador Therapeutics Inc.'s pending office actions.
